News

News

FYR Diagnostics Joins Forces with Science Exchange to Offer RNA Screening and Biomarker Services

PALO ALTO, CA, April 24, 2018 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced a collaboration with FYR Diagnostics to offer online access to its RNA screening and biomarker development services to scientists around the globe.

FYR Diagnostics is a privately held company headquartered in Missoula, Montana. The company offers unique biomarker discovery services including the identification and validation of genomic biomarkers such as miRNA. Since its inception, FYR Diagnostics has developed ongoing, collaborative relationships with both academic institutions and private companies all over the world to advance the discovery of objective measures of health leading up to and during disease.

“The FYR Diagnostics team has extensive experience screening miRNA samples, developing biomarkers, writing grants, and designing experiments with the goal of worldwide patent protection and commercialization. Our ability to quickly adapt and utilize novel technologies gives us a competitive edge over other research groups. We’re thrilled to join Science Exchange and looking forward to providing world-class research services to a global life science community,” says Sarj Patel, Ph.D., President of FYR Diagnostics.

“We are very excited to collaborate with FYR Diagnostics to make available its RNA screening and biomarker development services to scientists worldwide,” said Elizabeth Iorns, Ph.D., cofounder and CEO of Science Exchange.

“Science Exchange is committed to adding the most innovative and qualified service providers to our platform, so scientists have the services they need securely and readily available to aid their discoveries. FYR Diagnostics has impressed us with their superb progress in miRNA screening and biomarker development.”

About FYR Diagnostics

FYR Diagnostics is a Missoula, Montana-based company led by a team with diverse research and commercialization backgrounds. FYR Diagnostics provides miRNA screening and biomarker development services to other companies, leveraging its team’s successful background in these areas. Additionally, the company has a strong in-house pipeline focused on biomarker and diagnostic development.

 

Connect with FYR Diagnostics

Visit FYR Diagnostics’s Science Exchange profile to learn more and obtain quotes for their services.

ABOUT THE AUTHOR
author

Gursatya "Guru" Singh

Director of Scientific Content & Marketing

Gursatya Singh, also known as "Guru", manages the development and execution of strategic marketing initiatives to improve platform suppliers’ visibility and user experience. He is a true guru when it comes to helping suppliers better advertise their research services and providing buyers with easy access to recently commercialized external innovations. Whether working as a lab researcher, publishing scientific papers, or helping start life science startups, Guru believes in making the scientific world more collaborative and connected. Guru holds a master’s degree in biotechnology from the University of Delaware. Follow him on Twitter @Gursatya.

Leave a Reply

Your email address will not be published.